Farah Naz Pathan, MD
Psychiatry · San Jose
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 18
- 3 carriers
- Office
- 1
Offices
1 location · Precision Psychiatric Services Inc · 19 clinicians in this group
Plans that list them
18 plans · 3 carriers
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Pathan’s office at (408) 819-7310 to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
18 of 18 plans
| Advantage Care (HMO) | Align Senior Care | Listed | Oct 1, 2026 |
| Premier Care (HMO I-SNP) | Align Senior Care | Listed | Oct 1, 2026 |
| Senior Care (HMO I-SNP) | Align Senior Care | Listed | Oct 1, 2026 |
| Alignment Health Advantage PPO (PPO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health BreathEasy (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Clarity (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Harmony (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes CalPlus (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes Care (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Heart & Diabetes Choice (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Honor+ Plan (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health My Choice CalCare (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Silicon (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Sutter Advantage +More (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health smartHMO (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health the ONE (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| SCAN Strive (HMO C-SNP) | SCAN Health Plan | Listed | Oct 3, 2026 |
California Medical Board record
Licence C132429 · Current
Licensed to practise in California · since 2014 · expires 2028-02-29 · University of Sind, Liaquat Medical College.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
State licence records
1 licence
- Illinois 036110488Licensed Physician And Surgeon · since 2003 · expires 2017-07-31Not RenewedNo board action on this licenceCheck it with the state
We check Colorado, Delaware, Florida, Illinois, Maryland, New Jersey, New York, Tennessee, Texas, Virginia, Washington, plus California above. A state that is not in this list has not been checked, which is not the same as clear.
Drugs they prescribed that Part D paid
$8,124
Pharmacies billed $8,124 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 0% of their Part D prescriptions (0 of 165) in 2024. At or below the middle of the specialty; the typical psychiatry clinician is at 0%.
162 generic and fewer than 11 brand-name prescriptions · $8,124 in drug cost.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Trazodone | 20 | $274 | $12 |
Year by year
| 2024 | 165 | 41 | 0% (0) | None | $8,124 |
| 2021 | 35 | None | 0% (0) | 40% | $12,362 |
| 2016 | 16 | None | 0% (0) | None | $130 |
| 2015 | 112 | 19 | 0% (0) | 19% | $15,528 |
| 2014 | 788 | 86 | None | 16% | $83,089 |
| 2013 | 722 | 92 | None | 17% | $91,396 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2014: 25 drugs
| Abilify | 21 | $21,406 | $1,019 |
| Duloxetine | 60 | $12,803 | $213 |
| Ziprasidone | 32 | $6,337 | $198 |
| Venlafaxine Hcl Er | 16 | $990 | $62 |
| Bupropion Hcl Sr | 17 | $788 | $46 |
| Trazodone | 60 | $666 | $11 |
| Alprazolam Er | 15 | $635 | $42 |
| Topiramate | 12 | $622 | $52 |
| Lorazepam | 51 | $619 | $12 |
| Escitalopram | 43 | $552 | $13 |
| Paroxetine | 11 | $541 | $49 |
| Bupropion Xl | 11 | $509 | $46 |
| Oxcarbazepine | 13 | $479 | $37 |
| Clonazepam | 70 | $433 | $6 |
| Mirtazapine | 19 | $428 | $23 |
| Sertraline | 28 | $415 | $15 |
| Alprazolam | 38 | $388 | $10 |
| Amphetamine Salt Combo | 14 | $360 | $26 |
| Risperidone | 18 | $291 | $16 |
| Citalopram Hbr | 26 | $243 | $9 |
| Fluoxetine | 17 | $225 | $13 |
| Lamotrigine | 17 | $222 | $13 |
| Benztropine Mesylate | 15 | $215 | $14 |
| Zolpidem | 18 | $133 | $7 |
| Diazepam | 12 | $129 | $11 |
2013: 23 drugs
| Abilify | 16 | $23,237 | $1,452 |
| Ziprasidone | 37 | $13,500 | $365 |
| Cymbalta | 33 | $13,002 | $394 |
| Invega | 14 | $12,059 | $861 |
| Quetiapine | 22 | $4,055 | $184 |
| Perphenazine | 12 | $1,061 | $88 |
| Bupropion Hcl Sr | 15 | $1,047 | $70 |
| Oxcarbazepine | 29 | $954 | $33 |
| Amphetamine Salt Combo | 23 | $943 | $41 |
| Topiramate | 23 | $896 | $39 |
| Venlafaxine Hcl Er | 20 | $779 | $39 |
| Escitalopram | 11 | $747 | $68 |
| Mirtazapine | 16 | $615 | $38 |
| Trazodone | 55 | $539 | $10 |
| Sertraline | 24 | $506 | $21 |
| Buspirone | 13 | $413 | $32 |
| Clonazepam | 45 | $396 | $9 |
| Lorazepam | 35 | $389 | $11 |
| Fluoxetine | 27 | $376 | $14 |
| Citalopram Hbr | 31 | $332 | $11 |
| Alprazolam | 32 | $278 | $9 |
| Lamotrigine | 15 | $246 | $16 |
| Zolpidem | 36 | $211 | $6 |
Money from drug and device companies
$258 in 2025
| 2025 | 8 | 11 | None | $258 |
| 2024 | 4 | 6 | None | $136 |
| 2023 | 4 | 5 | None | $136 |
| 2022 | 4 | 5 | None | $215 |
| 2021 | 2 | 2 | None | $41 |
| 2020 | 1 | 1 | None | $50 |
| 2019 | 1 | 1 | None | $71 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Janssen Pharmaceuticals | Invega Sustenna | $48 | 2 payments
|
| BioXcel Therapeutics | Igalmi | $46 | 2 payments
|
| Neurocrine BioSciences | Ingrezza | $35 | 2 payments
|
| Vanda Pharmaceuticals | Fanapt | $31 | 1 payment
|
| E.R. Squibb & Sons L.L.C. | Cobenfy | $28 | 1 payment
|
| Otsuka Pharmaceutical Development & Commercialization | None | $25 | 1 payment
|
See all 11 published payments
| Vanda Pharmaceuticals | Meals · 2025-12-03 | Fanapt | $31 |
| Neurocrine BioSciences | Meals · 2025-09-22 | Ingrezza | $19 |
| Janssen Pharmaceuticals | Meals · 2025-09-19 | Invega Sustenna | $27 |
| BioXcel Therapeutics | Meals · 2025-09-18 | Igalmi | $25 |
| E.R. Squibb & Sons L.L.C. | Meals · 2025-09-05 | Cobenfy | $28 |
| Luye Pharma (USA) | Meals · 2025-08-29 | Erzofri Extended-Release | $22 |
| BioXcel Therapeutics | Meals · 2025-05-27 | Igalmi | $21 |
| Neurocrine BioSciences | Meals · 2025-05-23 | Ingrezza | $17 |
| Otsuka Pharmaceutical Development & Commercialization | Meals · 2025-05-16 | None | $25 |
| Janssen Pharmaceuticals | Meals · 2025-05-02 | Invega Sustenna | $22 |
| Abbvie | Meals · 2025-04-10 | Vraylar | $22 |
See earlier years (2024, 2023, 2022, 2021, 2020, 2019)
2024: $136
| Neurocrine Biosciences | Ingrezza | $67 | 3 payments
|
| Abbvie | Vraylar | $30 | 1 payment
|
| Indivior | Perseris | $25 | 1 payment
|
| Teva Pharmaceuticals USA | Uzedy | $14 | 1 payment
|
2023: $136
| Otsuka America Pharmaceutical | Rexulti | $54 | 2 payments
|
| Abbvie | Vraylar | $33 | 1 payment
|
| BioXcel Therapeutics | Igalmi | $26 | 1 payment
|
| Iti | Caplyta | $24 | 1 payment
|
2022: $215
| Janssen Pharmaceuticals | Spravato | $125 | 1 payment
|
| Alkermes | Aristada | $42 | 2 payments
|
| Otsuka America Pharmaceutical | Rexulti | $24 | 1 payment
|
| Otsuka Pharmaceutical Development & Commercialization | None | $24 | 1 payment
|
2021: $41
| Neurocrine Biosciences | Ingrezza | $21 | 1 payment
|
| Otsuka America Pharmaceutical | Abilify Maintena | $20 | 1 payment
|
2020: $50
| Indivior | Perseris | $50 | 1 payment
|
2019: $71
| Neurocrine Biosciences | Ingrezza | $71 | 1 payment
|
Professional record
- NPI
- 1013102771
- Licence
- CA C132429, IL 036110488California C132429: Current · expires 2028-02-29Illinois 036110488: Not Renewed
- Video visits
- Lists video visits
- Gender
- Female
More record details
- Sole proprietor
- No
- Taxonomy
- Psychiatry (2084P0800X); Federal specialty code 102L00000X (102L00000X); Federal specialty code 174400000X (174400000X)
- Mailing address
- 1376 Brookline Loop, Pleasanton, CA, 94566
- NPI first listed
- 2007-09-06
- NPI last updated
- 2023-01-05
- NPI record certified
- 2023-01-05
This is when the NPI record was last certified, not a medical board exam.
Extra NPI addresses: 4045 Stockdale Hwy, Bakersfield, CA, 93309
This office lists an electronic records connection.